A Phase 1 Trial of BYL719 Plus Letrozole or Exemestane for Patients with Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer - Stand Up To Cancer

Blog

Posted October 14, 2019

A Phase 1 Trial of BYL719 Plus Letrozole or Exemestane for Patients with Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.